China Faces Solomon's Choice, Encourage Greater Access Or Innovation
This article was originally published in PharmAsia News
Executive Summary
China's health-care leaders face a Solomon's choice when it comes to care, including drugs: whether to focus on access or innovation to fulfill the nation's needs.